Shengmin Wu

Title: Innovations by Shengmin Wu in Hyperlipidemia Treatment

Introduction

Shengmin Wu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of health and nutrition, particularly in the treatment and prevention of hyperlipidemia. His innovative approach combines various natural components to create effective compositions for managing cholesterol levels.

Latest Patents

Shengmin Wu holds a patent for a composition aimed at treating and preventing hyperlipidemia. This composition consists of phytosterols and phytostanols (30-50%), flavones derived from bamboo leaf (20-40%), procyanidins (10-25%), and β-glucan (5-20%) by weight. The formulation demonstrates marked therapeutic effects in preventing and treating hyperlipidemia compared to combinations of fewer components. When utilized in supplementary nutrient foods or medicaments, this composition effectively lowers cholesterol and triglyceride levels in the blood, making it beneficial for treating cardiovascular diseases, coronary heart disease, and atherosclerosis.

Career Highlights

Shengmin Wu is associated with Fenchem Enterprises, Ltd., where he continues to innovate in the field of health-related compositions. His work focuses on developing natural solutions that can improve health outcomes for individuals suffering from lipid-related conditions.

Collaborations

Shengmin Wu collaborates with Juan Liu, contributing to the advancement of research and development in their field. Their partnership enhances the potential for innovative solutions in health and nutrition.

Conclusion

Shengmin Wu's contributions to the treatment of hyperlipidemia through innovative compositions highlight the importance of natural ingredients in health solutions. His work not only addresses a significant health issue but also paves the way for future advancements in nutritional science.